Schedule 13D ownership disclosure
KINIKSA PHARMACEUTICALS INTL
Security class unavailable · CUSIP: G52694109
Event date: 2024-10-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,128,869
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-107086
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Oct 08, 2024
- Reporting period
- Oct 04, 2024
- Description
- Schedule 13D beneficial ownership